Jerusalem-based Chiasma has raised $33.8 million of a proposed $56.3 million round, despite cancellation of an approximately $595 million deal with global biotech Roche last summer. New funds were provided by a portfolio of investors including MPM Capital, Abingworth, 7-Med Health Ventures LP, ARCH Venture Partners and F2 and F3 Ventures. Chiasma has shown promise as a ...
Read More »Home / Drug Delivery
NeuroDerm Share Prices Soar After Positive Results in Phase IIa Parkinson’s Trial המניה של נוירודרם הוכפל לאור תוצאות ניסוי לטיפול בפרקינסון
Rehovot-based NeuroDerm Ltd. (NASDAQ: NDRM) ended 2014 on a high note as it saw its share price more than double following announcement of positive results in a Phase IIa Parkinson’s drug trial. According to the company, administration of a continuous subcutaneous high-level dose of ...
Read More »Syqe Medical Helps Standardize Therapeutic Cannabis המצאה של סאיקי מדיקל בע"מ מספקת מינון סטנדרטי של קנאביס טיפולי
Many physicians hesitate to prescribe medical marijuana for pain relief because of its variability in efficiency, largely due to current dosage techniques. Tel Aviv-based Syqe Medical is giving these doctors a new option: more fine-tuned control over their patients’ marijuana ...
Read More »